Ruben Osnabrugge
Consultor / Asesor en EQT Life Sciences Group BV .
Origen de la red de primer grado Ruben Osnabrugge.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Erasmus University Rotterdam
69
| College/University | Other Consumer Services | 69 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
23
| Subsidiary | Investment Managers | 23 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ruben Osnabrugge a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Rotterdam School of Management | College/University | Chief Executive Officer Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Leiden | College/University | Director/Board Member Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Amsterdam | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| Radboud University Nijmegen | College/University | Graduate Degree Graduate Degree General Counsel | |
| University of Bocconi | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Symbid BV
 Symbid BV Internet Software/ServicesTechnology Services Part of Seedblink Crowd SA, Symbid BV operates as a crowd investing platform. The company is based in Rotterdam, Netherlands. The Dutch company was founded in 2011 by Korstiaan Zandvliet, Robin Slakhorst, Maarten van der Sanden, Jeroen Bontje. Korstiaan Zandvliet has been the CEO since 2011. Symbid was acquired by Seedblink Crowd SA on August 16, 2022. | Internet Software/Services | Chief Executive Officer Founder Founder | |
| SINCERITY APPLIED MATERIALS HOLDINGS CORP. | Wholesale Distributors | Founder Founder Founder | |
Rivean Capital BV
 Rivean Capital BV Investment ManagersFinance Rivean Capital BV (Rivean Capital) is a private equity subsidiary of Rivean Capital Management Holding BV founded in 1982. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Director of Investments Private Equity Investor Private Equity Investor | |
Holland Capital Management BV
 Holland Capital Management BV Investment ManagersFinance Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
AlpInvest Partners BV
 AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Investor | |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Sales & Marketing Analyst-Equity Analyst-Equity | |
| Delft University of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Erasmus School of Economics | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Standard Investment Management BV
 Standard Investment Management BV Investment ManagersFinance Standard Investment Management BV (Standard Investment) is a private equity firm founded in 2004 by Idgar van Kippersluis and Hendrik Jan ten Have. The firm is headquartered in Amsterdam, the Netherlands with additional offices in Etterbeek, Belgium and Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ice Lake Capital Management BV
 Ice Lake Capital Management BV Investment ManagersFinance Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Founder Private Equity Investor | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Opdidakt BV
 Opdidakt BV MiscellaneousMiscellaneous Opdidakt BV operates learning and development research institutions. It offers dyslexia guidance, remedial teaching, first and second line psychology, socio-emotional support, and homework supervision services. The company is headquartered in 's-Hertogenbosch, the Netherlands. | Miscellaneous | Chairman Comptroller/Controller/Auditor | |
Mckinsey & Co. /Amsterdam/
 Mckinsey & Co. /Amsterdam/ Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., Mckinsey & Co. /Amsterdam/ provides management consultancy services. The company is based in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal Consultant / Advisor | |
Dellin Investments
 Dellin Investments Investment ManagersFinance Dellin Investments (Dellin Investments) is a private equity/venture capital firm founded in 2010 by Frank van Lint. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor Private Equity Investor | |
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Director/Board Member | |
| University of Twente | College/University | Corporate Officer/Principal Graduate Degree | |
| PT INDONESIA KENDARAAN TERMINAL TBK | Marine Shipping | Chief Executive Officer Director of Finance/CFO | |
Bolster Investment Partners BV
 Bolster Investment Partners BV Investment ManagersFinance Bolster Investment Partners BV (Bolster Investment Partners) is an independent private equity firm. The firm was founded by Mark van Rijn, Joost Bakhuizen, Michiel van Wissen and Paul Vogelzang in 1982. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Technische Universiteit Eindhoven | College/University | Doctorate Degree Undergraduate Degree | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
| Duisenberg School of Finance | College/University | Director/Board Member Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Vitruvian Partners LLP
 Vitruvian Partners LLP Investment ManagersFinance Vitruvian Partners LLP (Vitruvian Partners) is a private equity firm founded in 2006 by Ian Riley, Michael Risman, Toby Wyles, Mark Harford and David Nahama. The firm is headquartered London, the United Kingdom with offices across the globe. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Países Bajos | 29 |
| Bélgica | 9 |
| Reino Unido | 4 |
| Francia | 3 |
| Suiza | 3 |
Sectorial
| Consumer Services | 17 |
| Finance | 14 |
| Health Technology | 13 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 199 |
| Graduate Degree | 86 |
| Private Equity Investor | 85 |
| Corporate Officer/Principal | 72 |
| Undergraduate Degree | 61 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Pauline van der Meer Mohr | 34 |
| Martijn Kleijwegt | 33 |
| René Kuijten | 30 |
| Rudy Dekeyser | 29 |
| Angelien G. Z. Kemna | 21 |
| John Paul de Koning | 21 |
| Anne Portwich | 16 |
| Vincent Brichard | 15 |
| Hans Clevers | 14 |
| Bruno Luc Myriam Holthof | 14 |
| Clemens A. van Blitterswijk | 12 |
| Mark Wegter | 11 |
| Hubert Verbeek | 11 |
| Felice Verduyn-van Weegen | 9 |
| Cillian King | 9 |
- Bolsa de valores
- Insiders
- Ruben Osnabrugge
- Conexiones Empresas
